This website uses cookies to improve the site and user experience. By continuing to browse this site,
you agree to accept our use of cookies. For more information, please review our Cookies Policy
SGO 2023
Presentations

Tucatinib | Uterine and Cervical Cancer | Poster #162
A phase 2 basket study of tucatinib and trastuzumab in solid tumors with human epidermal growth factor receptor 2 alterations: uterine and cervical cancer cohorts (SGNTUC-019, trial in progress)